Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lily Bioceuticals is a U.S.-based skincare and cosmeceutical company marketing anti-aging topical products and wearable cosmetic skin-film products. The brand appears to operate through Lily Bioceuticals LLC and is described in company press materials as being owned by Bio-Nature Laboratories of New Jersey. Its commercial portfolio includes NAD+/NR-themed anti-aging skincare, herbal/cosmeceutical serums and creams, and Beyond Flawless Second Skin, a cosmetic synthetic "second skin" product for under-eye bags and wrinkles. The company blends traditional herbal ingredients with Western cosmetic science, peptides, retinol, vitamins, and polymer/graphene-based film-forming technology. It is not a therapeutic biotech drug developer in the conventional pharma sense, but it is health/beauty adjacent and commercially active in anti-aging skincare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lily Bioceuticals.